Explore opportunities

Search by company name (Bolden, Pax, OncoLux, Nabsys), asset id, or title. Each card links to a full dossier with cited evidence.

Loading filters…

Tier Bip_neural_decoding_legacy
Core neural signal decoding & cortical interface (Donoghue era)

Foundational BMI decode patents—FTO diligence essential for new neurotech entrants.

Royalty or field-of-use license vs wireless/speech sub-families.

Entity: BrainGatePatents: 5Stage: clinical legacy
US7212851US7392079US7280870US20200104689A1US9851795U01DC017844
Open dossier
Tier APatent gapgap_ni2o_kiwi_bci
KIWI wireless micro-implant BCI (ni2o)

KIWI wireless micro-implant BCI—Providence HQ with BrainGate FTO diligence.

Nurosene partnership + strategic path—harvest Howard/ni2o USPTO vs Brown patents.

Entity: ni2oPatents: 3Stage: preclinical grant
US20260137929A1US20210196980A1US20210263589A1
Open dossier
Research synthesis from public sources (NIH RePORTER, ClinicalTrials.gov, PubMed, USPTO, company press). Not investment advice, legal opinion, or clinical guidance. Verify cap tables, license chains, and trial status in data rooms before term sheets.